- Home
- CVAC vs BTO Comparison
CVAC vs BTO Comparison
Compare CVAC & BTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVAC
- BTO
- Stock Information
- Founded
- CVAC 2000
- BTO 1994
- Country
- CVAC Germany
- BTO United States
- Employees
- CVAC N/A
- BTO N/A
- Industry
- CVAC Biotechnology: Pharmaceutical Preparations
- BTO Investment Managers
- Sector
- CVAC Health Care
- BTO Finance
- Exchange
- CVAC Nasdaq
- BTO Nasdaq
- Market Cap
- CVAC 812.1M
- BTO 703.7M
- IPO Year
- CVAC 2020
- BTO N/A
- Fundamental
- Price
- CVAC $4.10
- BTO $36.74
- Analyst Decision
- CVAC Hold
- BTO
- Analyst Count
- CVAC 3
- BTO 0
- Target Price
- CVAC $10.00
- BTO N/A
- AVG Volume (30 Days)
- CVAC 1.2M
- BTO 54.2K
- Earning Date
- CVAC 11-12-2024
- BTO 01-01-0001
- Dividend Yield
- CVAC N/A
- BTO 9.13%
- EPS Growth
- CVAC N/A
- BTO N/A
- EPS
- CVAC N/A
- BTO N/A
- Revenue
- CVAC $70,565,734.00
- BTO N/A
- Revenue This Year
- CVAC $742.57
- BTO N/A
- Revenue Next Year
- CVAC N/A
- BTO N/A
- P/E Ratio
- CVAC N/A
- BTO N/A
- Revenue Growth
- CVAC 75.11
- BTO N/A
- 52 Week Low
- CVAC $2.22
- BTO $22.95
- 52 Week High
- CVAC $5.28
- BTO $32.81
- Technical
- Relative Strength Index (RSI)
- CVAC 62.06
- BTO 56.32
- Support Level
- CVAC $3.89
- BTO $36.01
- Resistance Level
- CVAC $4.32
- BTO $36.15
- Average True Range (ATR)
- CVAC 0.33
- BTO 0.86
- MACD
- CVAC 0.03
- BTO 0.25
- Stochastic Oscillator
- CVAC 54.27
- BTO 84.92
About CVAC CureVac N.V.
CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid, or mRNA. The company was founded in 2000 and had its initial public offering in August 2020. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and Covid vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
About BTO John Hancock Financial Opportunities Fund
John Hancock Financial Opportunities Fund is the United States based closed-end, diversified management investment company. Its investment objective is to provide a high level of total return consisting of long-term capital appreciation and current income. The portfolio composition of the fund includes common stocks, corporate bonds, preferred securities, investment companies, and short-term investments.